Jefferies Maintains Buy Rating and PT on KND After RehabCare Acquisition Finalized

According to a recent report, Jefferies has reiterated a Buy rating and $30.00 price target on Kindred Healthcare KND after the company announced the completion of the RehabCare acquisition yesterday. In the report, Jefferies said, "In our view, the combination of these two companies is strategically sound as it should enhance KND's growth profile and allow for strong cash flow generation that can be used to delever the company's balance sheet and fund additional acquisition and development activity." KND closed yesterday at $25.06.